Subscribe To

Price Alert Latest News Economic Calendar News

ULBI / Ultralife Corporation (ULBI) CEO Michael Popielec on Q2 2022 Results - Earnings Call Transcript

Ultralife Corporation. (NASDAQ:ULBI ) Q2 2022 Earnings Conference Call July 28, 2022 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Popielec - President and Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Operator Good day, and welcome to this Ultralife Corporation Second Quarter 2022 Earnings Release Conference Call. Read More

Demo Live Account See Partner Details

Content Topics

Ultralife

Corporation

ULBI

Michael

Popielec

2022

Results

ulbi

Earnings

Transcript

Stock

Posted: Jul 30 2022, 07:50

Author Name: Seeking Alpha

ULBI News

By Seeking Alpha
October 26, 2023

Ultralife Corporation (ULBI) Q3 2023 Earnings Call Transcript

Ultralife Corporation (NASDAQ:ULBI ) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Jody Burfening - Investor Relat

By GlobeNewsWire
October 12, 2023

Ultralife Corporation to Report Third Quarter Results on October 26, 2023

NEWARK, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended Septem

By Seeking Alpha
October 11, 2023

Ultralife: Stock To Outperform With Growth From Multiple Industries

Ultralife's strong revenue and earnings growth can drive the stock to above-average gains. The valuation is reasonable, leaving room for upside for th

By Seeking Alpha
October 10, 2023

Ultralife Corporation: On The Up, But Wait For A Better Entry Point

Ultralife manufactures portable power solutions and communication systems for a range of industries. The company has put in place certain initiatives

By Seeking Alpha
July 31, 2023

Ultralife: Backlog Increase And FCF Growth Imply Undervaluation

Ultralife Corporation reports an impressive increase in backlog, indicating potential for future net sales growth. Communications Systems segment show

By Seeking Alpha
July 27, 2023

Ultralife Corporation (ULBI) Q2 2023 Earnings Call Transcript

Ultralife Corporation (NASDAQ:ULBI ) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna

By Seeking Alpha
April 30, 2023

Ultralife Corporation (ULBI) Q1 2023 Results - Earnings Call Transcript

Ultralife Corporation (NASDAQ:ULBI ) Q1 2023 Earnings Conference Call April 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna

By GlobeNewsWire
April 13, 2023

Ultralife Corporation to Report First Quarter Results on April 27, 2023

NEWARK, N.Y., April 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.